Sandalova, S. (2026). Early Post-Marketing Safety Profile of Fezolinetant in FAERS: A Disproportionality Analysis With Emphasis on Hepatotoxicity. International Journal of Medical Students. Retrieved from https://ijms.info/IJMS/article/view/4780